L'Aquila, Italy

Luigi Pellegrini

This inventor holds 1 USPTO granted patent. Top assignee: Dompé S.p.a.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luigi Pellegrini. Retrieved from https://idiyas.com/inventor/luigi-pellegrini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Luigi Pellegrini: Innovator in Antitussive Agents

Introduction

Luigi Pellegrini is a notable inventor based in L'Aquila, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitussive agents. His work has led to advancements that benefit both the medical community and patients.

Latest Patents

Pellegrini holds a patent for 1,3-dioxolanes with antitussive activity. This patent, titled "(S)-3-(4-Phenyl-1-piperazinyl)-1,2-propanediol cyclic acetals useful as antitussive agents and as intermediates for the preparation of levodropropizine and the salts thereof, as well as a process for the preparation of said acetals," showcases his innovative approach to creating effective cough suppressants.

Career Highlights

Throughout his career, Pellegrini has been associated with Dompé S.p.a., a prominent pharmaceutical company. His work there has allowed him to focus on research and development in the field of antitussive medications. His dedication to innovation has positioned him as a key figure in his area of expertise.

Collaborations

Pellegrini has collaborated with esteemed colleagues such as Marcello Allegretti and Maria Candida Cesta. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Luigi Pellegrini's contributions to the field of pharmaceuticals, particularly in antitussive agents, highlight his innovative spirit and dedication to improving healthcare. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…